5 results for "clinical-trials"
FDA cuts trial lag with real-time data from AstraZeneca and Amgen. $6.4B drug patent extended until 2031. Here's your protocol to navigate faster approvals, AI-
Hungarian science is rapidly evolving—offering fresh insights for longevity and biohacking protocols. Discover how this ecosystem is redefining translational re
Boehringer Ingelheim's experimental obesity drug achieves 16.6% weight loss in Phase 2 trials. What this means for the next generation of weight-loss treatments
Astellas reenters clinic with next-gen XLMTM gene therapy after fatal trial. Meanwhile, Intellia's CRISPR cuts swelling attacks by 87% in Phase 3. The new AAV8
Nature's new book 'Beyond Belief' reveals how data-driven decisions are reshaping health. Learn the 3 protocols to apply this revolution today.
